Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease - Takeaways - MDSpire

Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease

  • By

  • Enrique Ángel-Gomis

  • Oriol Juanola

  • Esther Caparrós

  • Rubén Francés

  • April 20, 2026

  • 0 min

Share

  • 1

    Chronic liver disease (CLD) is a prevalent condition associated with high morbidity and mortality worldwide.

  • 2

    Hepatic antigen presenting cells (hAPCs) play a crucial role in maintaining immune tolerance in the liver.

  • 3

    Epigenetic mechanisms significantly influence the regulation of hAPCs and contribute to the progression of CLD.

  • 4

    The dysregulation of hAPCs during CLD leads to impaired immune surveillance and chronic inflammation.

  • 5

    Understanding the epigenetic profiling of hAPCs may provide therapeutic insights for managing inflammatory responses in CLD.

Original Source(s)

Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease

  • by Enrique Ángel-Gomis, Oriol Juanola, Esther Caparrós, Rubén Francés

  • April 20, 2026

Related Content

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

The Relationship Between Vitamin D, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Type 2 Diabetes: A Comprehensive Review of Global Insights and Perspectives for Sub-Saharan Africa